APEN - エルパス （Apollo Endosurgery Inc.）

Apollo Endosurgery is now part of Boston Scientific (BSX) as the latter''s acquisition of the former is now complete. Read more here.

Apollo Endosurgery Inc. (NASDAQ:APEN)’s traded shares stood at 13.04 million during the latest session, with the company’s beta value hitting 2.32. At the last check today, the stock’s price was $9.94, to imply an increase of 1.17% or $0.11 in intraday trading. The APEN share’s 52-week high remains $10.30, putting it -3.62% down since that … After Sinking 0.96% During Past Week, Is Apollo Endosurgery Inc. (NASDAQ: APEN) Still A Buy? Read More »

Apollo Endosurgery Inc. (NASDAQ:APEN) concluded the trading at $9.83 on Friday, January 27 with a fall of -0.20% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $9.85 and 5Y monthly beta was reading 2.29 with its price kept floating in the … Apollo Endosurgery Inc. (APEN) Stock Behavior Isn’t As Predictable As You Think Read More »

Apollo Endosurgery''s (NASDAQ: APEN ) short percent of float has fallen 63.08% since its last report. The company recently reported that it has 425 thousand shares sold short , which is 1.2% of all regular shares that are available for trading. Based on its trading volume, it would take traders 0.6 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price … Full story available on Benzinga.com

https://www.investing.com/news/pro/stifel-downgrades-apollo-endosurgery-to-hold-432SI-2972546

Apollo Endosurgery, Inc. (NASDAQ:NASDAQ:APEN) Q3 2022 Earnings Conference Call November 1, 2022 4:30 PM ET Company Participants Matt Kreps – Investor Relations Chas McKhann – Chief…

The following slide deck was published by Apollo Endosurgery, Inc.

Apollo Endosurgery press release (APEN): Q3 GAAP EPS of -$0.28 misses by $0.05.Revenue of $19.57M (+19.7% Y/Y) beats by $1.42M.The company is raising its FY2022 revenue guidance to…

AUSTIN, TX / ACCESSWIRE / October 18, 2022 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestin…

Patients undergoing ESG achieved 24% total body weight loss in a bariatric surgery practice in a community setting.AUSTIN, TX / ACCESSWIRE / August 31, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive …

Apollo Endosurgery, Inc. (NASDAQ:NASDAQ:APEN) Q3 2022 Earnings Conference Call November 1, 2022 4:30 PM ET Company Participants Matt Kreps – Investor Relations Chas McKhann – Chief…

The following slide deck was published by Apollo Endosurgery, Inc.

Apollo Endosurgery press release (APEN): Q3 GAAP EPS of -$0.28 misses by $0.05.Revenue of $19.57M (+19.7% Y/Y) beats by $1.42M.The company is raising its FY2022 revenue guidance to…

AUSTIN, TX / ACCESSWIRE / October 18, 2022 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestin…

Patients undergoing ESG achieved 24% total body weight loss in a bariatric surgery practice in a community setting.AUSTIN, TX / ACCESSWIRE / August 31, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive …